As the world continues to grapple with COVID-19, companies race to develop vaccines and the impending U.S. presidential election hangs in the balance, the global healthcare industry is experiencing one of its highest-profile moments in recent history.

Financial markets are watching closely, as few other sectors seem to show as many signs of activity for capital raising, consolidation or investment. This presentiment underpinned Yielda’s 18th annual Global Healthcare Conference held virtually last month, where more than 350 companies and 1,200 investors gathered to learn and discuss key questions, insights and corporate outlooks.

Indeed, the tech acceleration theme, including the rise of telehealth, deep-learning for computational pathology and physician-recommended software as therapeutics, excited many participants. As coronavirus drives urgency for innovation and investor focus on potential winners, as well as greater access to capital, many are also assessing demand for corporate transactions.